Revenue growth in the SMO business
First written in FY2016. 4 of 5 entries say "Worsened", first in FY2017-Q1. Latest entry: FY2017.
No other company in this theme has enough history to compare yet.
- FY2017WorsenedAnnual report
「As a result, revenue was ¥173.485 million, down 50.9% year on year, and the company recorded an operating loss of ¥8.506 million, compared with operating profit of ¥100.304 million in the same period of the previous year.」
Full-year revenue in the SMO business fell 50.9% year on year, and the business swung from operating profit to an operating loss. - FY2017-Q3WorsenedAnnual report
「As a result, revenue was ¥123.520 million, down 60.8% year on year, and the company recorded an operating loss of ¥14.035 million, compared with operating profit of ¥84.030 million in the same period of the previous year.」
Revenue in the SMO business fell 60.8% year on year, and the business continued to operate at a loss after having swung from operating profit in the same period of the previous year. - FY2017-Q2WorsenedAnnual report
「As a result, revenue was ¥77.022 million, down 65.3% year on year, and the company recorded an operating loss of ¥20.406 million, compared with operating profit of ¥55.398 million in the same period of the previous year. Revenue is expected to increase through progress in clinical trials and the acquisition of new projects, and we expect to post an operating profit for the full year.」
Revenue in the SMO business fell 65.3% year on year, and the business swung from operating profit in the same period of the previous year to an operating loss. The forecast for a full-year operating profit remains unchanged. - FY2017-Q1WorsenedAnnual report
「As a result, revenue was ¥36.550 million, down 70.1% year on year, and the company recorded an operating loss of ¥14.412 million, compared with operating profit of ¥31.019 million in the same period of the previous year.」
The SMO business swung from operating profit in the same period of the previous year to an operating loss, while revenue fell 70.1% year on year. - FY2016First statedAnnual report
「As a result, revenue was ¥353.395 million, up 50.8% year on year, and operating profit was ¥100.304 million, up 410.6%, representing substantial increases.」
The SMO business recorded substantial year-on-year increases in revenue and operating profit.